Stephen Johnson

TL;DR: This work confirms the existence of a distinct breast microbiome and differences between the breast tissue microbiome in benign and malignant disease, and identifies distinct microbial communities in breast tissues from women with cancer as compared to women with benign breast disease.

TL;DR: A plausible biological mechanism to explain the links between shifts in the microbiota and colorectal cancer is suggested and could promote a colonic environment that supports the growth of bile-tolerant microbes such as Bilophilia and Desulfovibrio.

TL;DR: The objective was to characterize the microbiota and associate the microbiota with the tumor expression profiles, for 668 breast tumor tissues and 72 non-cancerous adjacent tissues and further unraveling this complicated interplay should enable us to better diagnose and treat breast cancer patients.

TL;DR: In this article, the authors analyzed 16S rRNA gene sequences from the fecal microbiota of patients with adenomas and without colorectal cancer and found that the altered adenoma profile is predicted to increase primary and secondary bile acid production, as well as starch, sucrose, lipid, and phenylpropanoid metabolism.

TL;DR: A subset of patients with IBS, especially in PI-IBS, has substantially high faecal PA, greater symptoms, impaired barrier and reduced microbial diversity.